Navigation Links
The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma

Free, Interactive Telephone Education Program Features Myeloma Experts,

Melissa Alsina, M.D. and Kathy A. Daily, R.N.

WHITE PLAINS, N.Y., Oct. 4 /PRNewswire/ -- Myeloma patients can learn about managing side effects during a free telephone education workshop sponsored by The Leukemia & Lymphoma Society, and led by myeloma experts Melissa Alsina, M.D., and Kathy A. Daily, R.N. of the H. Lee Moffitt Cancer & Research Institute.

"Managing Myeloma Side Effects: What you Need to Know," is scheduled for Wednesday, October 10, 2007, 12 noon -- 1:30 p.m. ET. Dr. Alsina, associate professor of medicine, for the bone marrow transplant program, and Kathy A. Daily, transplant nurse specialist, from the H. Lee Moffitt Cancer & Research Institute in Tampa, FL., will discuss diagnosis and treatment options of patients with myeloma, including information on emerging therapies under study. They will also discuss symptom and side effect management, information on the role of clinical trials and drug therapies in the advancement of myeloma treatment, and quality of life issues. A question-and-answer period will follow.

"The more information Myeloma patients have, the better decisions they can make in regard to treatment and side effect management," explains Robin Kornhaber, M.S.W., the Society's senior vice president of patient services. "We encourage patients, caregivers and healthcare providers to participate in this informative program."

This educational program is supported by Celgene and Millennium Pharmaceuticals. Nurses and social workers who participate in the program have an opportunity to earn 1.5 Continuing Education contact hours.


To register, call toll free by phone (866) 992-9950, ext. 304 or toll free by fax (888) 991-9951; email (enter "Myeloma" in the subject field) or visit Registrants will receive an information packet and toll free dial-in number within 7-10 days of signing up.

About Myeloma

Myeloma is a cancer of the plasma cells, a type of white blood cell found in many tissues of the body, but primarily in the bone marrow. In myeloma, a B lymphocyte, the cell that forms plasma cells, becomes malignant. It grows continuously and forms masses of plasma cells, especially in the marrow, destroying normal blood cell production.

Malignant plasma cells produce an abnormal protein called monoclonal immunoglobulin. Immunoglobulins (or antibodies) are an important part of the body's natural defense against infection because they recognize microbes that invade the body and permit then to be removed and destroyed. The onset of myeloma interferes with normal production of antibodies and makes myeloma patients susceptible to infections.

Often the first symptom of myeloma is bone pain caused by the effects of malignant plasma (myeloma) cells in the marrow. Patients may have anemia, tire more easily and feel weak. Fractures may occur as a result of the weakened bones. Recurrent infections may be an early sign of disease.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society, headquartered in White Plains, NY, with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The Society's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, the Society has invested more than $550 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, the Society made 5.1 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit or call the Society's Information Resource Center (IRC), a call center staffed by Masters-level professionals who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

SOURCE The Leukemia & Lymphoma Society
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. GLEEVEC - An Oral treatment for leukemia
2. GLEEVEC - An Oral treatment for leukemia
3. Looking Towards More Effective Leukemia Treatment
4. Cyclosporin A Treats Leukemia Complications
5. Exposure to EMF may cause leukemia
6. A new vaccine for leukemia
7. Leukemia pill shows promise against stomach cancer
8. Aspirin Lowers Leukemia Risk
9. Hope for Chemo-Resistant Leukemia Patients
10. Genes Found To Help Leukemia Treatment
11. Diet Found To Offer Protection Against Leukemia
Post Your Comments:
(Date:11/26/2015)... ... 2015 , ... WorldCare International, Inc., the first company to ... Benefits Conference. The Employee Benefits Conference was hosted by the International Foundation of ... 2015. The conference was held at the Hawaii Convention Center in Honolulu, Oahu, ...
(Date:11/26/2015)... , ... November 26, 2015 ... ... platform for mental health and wellness consultation, has collaborated with Women’s Web ... address their reader’s queries on topics on mental and emotional well-being relationship, ...
(Date:11/25/2015)... OAK BROOK, Ill. (PRWEB) , ... November 25, ... ... sometimes larger and potentially more aggressive than those found on mammography, according to ... cases MRI findings of additional cancers not seen on mammography may necessitate a ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... the perfect dish and pleasing the palates of attendees is of the utmost ... dish to a seasonal get-together, give these recipes a try this holiday season. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical ... once again for its stellar workplace culture with the company’s Cincinnati office being ... Medical Solutions’ Cincinnati office was named a finalist in Cincinnati Business Courier’s 13th ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , 26 november 2015 ... kondigt de geplande investering aan van ten ... de laboratoria en het mondiale hoofdkantoor in ... uitbreiding zal resulteren in extra kantoorruimte en ... aan de groeiende behoeften van de farmaceutische ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and Markets ( ... Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise in ... Demand " report to their offering. ... Boston scientific and others. ... including Medtronic, Biotronik, Boston scientific and ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Testing Market: Supplier Shares, Competitive ... offering.  --> ) ... "2016 Future Horizons and Growth Strategies ...
Breaking Medicine Technology: